MyPsoriasisTeam

Tremfya (guselkumab) is a biologic medication approved by the FDA for treating moderate to severe plaque psoriasis. It's administered as an injection under the skin. Janssen, the company behind Tremfya, is currently conducting additional research to study its effectiveness across diverse populations. While everyone responds Show Full Answer

Tremfya (guselkumab) is a biologic medication approved by the FDA for treating moderate to severe plaque psoriasis. It's administered as an injection under the skin. Janssen, the company behind Tremfya, is currently conducting additional research to study its effectiveness across diverse populations. While everyone responds differently to medications, many MyPsoriasisTeam members have found success with biologics after trying various treatments. It's important to:

• Give the medication time to work
• Keep track of your symptoms and progress
• Stay in communication with your healthcare team
• Manage stress levels, as stress can trigger flares
• Remember that finding the right treatment can take time

Stay hopeful and patient as your body adjusts to the new medication.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Janssen Launches Study To Improve Care for People of Color With Psoriasis

Living With Psoriatic Arthritis: A Q&A With MyPsoriasisTeam Members